Evaluation of Lung Cancer Incidence Dynamics in Kyrgyzstan

Author:

Bazhanova Aliia,Akhunbaev Stalbek,Soodonbekov Enverbek,Nurtazinova Gaukhar,Telmanova ZhansayaORCID,Igissinov Nurbek

Abstract

Background: In 2020, more than half of all cases (59.6%) of lung cancer of both sexes and 61.9% of lung cancer deaths were registered in Asia. In Kyrgyzstan, lung cancer is the second most common cancer after stomach cancer (11.2% of all diagnosed malignancies). Objective: The study is to conduct a component analysis of the dynamics of the incidence of lung cancer (LC) in Kyrgyzstan. Methods: Primary data were for registered patients with LC (ICD 10 – C34) in the whole country during the period of 2010-2019. Evaluation of changes in LC incidence in the population of Kyrgyzstan was performed using component analysis according to the methodological recommendations. Results: The study period, 4,931 new cases of LC were recorded. During the studied years an average age of patients with lung cancer was 61.4 years (95%CI=60.9-61.9). Age-related indicators of the incidence of LC had a peak in 65+ years in both sexes (84.9±3.20/0000), male (159.5±6.40/0000) and female (35.5±2.20/0000) population. Trends in the ASIR of LC in the entire population tended to decrease in all age groups. The incidence rate decreased from 8.00/0000 (2010) to 7.20/0000 in 2019 and the overall decline was −0.80/0000, including due to the age structure – ∑ΔA=+1.20/0000, due to the risk of acquiring illness – ∑ΔR=−1.80/0000 and their combined effect – ∑ΔAR=−0.20/0000. The component analysis revealed that the increase in the number of patients with LC was mainly due to the growth of the population (ΔP=+17.9%), changes in its age structure (ΔA=+15.4%). Conclusion: In the Republic of Kyrgyzstan, the incidence of lung cancer is decreasing. According to the component analysis, in general, the increase in the number of patients was due to demographic factors, while the decrease in morbidity was influenced by a decrease in the risk of acquiring illness. The implementation of the results of this study is recommended in the management of anticancer measures for lung cancer.

Publisher

Scientific Foundation SPIROSKI

Subject

General Medicine

Reference50 articles.

1. Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M et al. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer; 2020A. Available from: https://gco.iarc.fr/today [Last accessed 2022 Feb 11].

2. The National Lung Cancer Audit Report 2016. London: Royal College of Physicians; 2016.

3. Schabath MB, Cote ML. Cancer progress and priorities: Lung cancer. Cancer Epidemiol Biomarkers Prev. 2019;28(10):1563-79. https://doi.org/10.1158/1055-9965.EPI-19-0221

4. MacRosty CR, Rivera MP. Lung cancer in women: A modern epidemic. Clin Chest Med. 2020;41(1):53-65. https://doi.org/10.1016/j.ccm.2019.10.005

5. National Cancer Institute. Cancer Stat Facts: Lung and Bronchus Cancer; 2021. Available from: https://seer.cancer.gov/statfacts/html/lungb.html [Last accessed on 2021 Jan 15].

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3